Howe & Rusling’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $646K | Sell |
4,637
-39
| -0.8% | -$5.46K | 0.04% | 159 |
|
|
2025
Q4 | $574K | Buy |
4,676
+21
| +0.5% | +$2.55K | 0.04% | 163 |
|
|
2025
Q3 | $517K | Sell |
4,655
-56
| -1% | -$6.37K | 0.04% | 176 |
|
|
2025
Q2 | $522K | Sell |
4,711
-39
| -0.8% | -$4.15K | 0.04% | 163 |
|
|
2025
Q1 | $532K | Buy |
4,750
+46
| +1% | +$4.75K | 0.04% | 155 |
|
|
2024
Q4 | $435K | Buy |
4,704
+115
| +3% | +$10.4K | 0.04% | 172 |
|
|
2024
Q3 | $385K | Sell |
4,589
-30
| -0.6% | -$2.29K | 0.03% | 189 |
|
|
2024
Q2 | $317K | Sell |
4,619
-276
| -6% | -$18.4K | 0.03% | 196 |
|
|
2024
Q1 | $359K | Buy |
4,895
+65
| +1% | +$5K | 0.03% | 186 |
|
|
2023
Q4 | $391K | Buy |
4,830
+77
| +2% | +$5.99K | 0.04% | 154 |
|
|
2023
Q3 | $356K | Buy |
4,753
+52
| +1% | +$4K | 0.04% | 155 |
|
|
2023
Q2 | $362K | Buy |
4,701
+102
| +2% | +$8.13K | 0.04% | 160 |
|
|
2023
Q1 | $382K | Sell |
4,599
-2
| -0% | -$166 | 0.05% | 154 |
|
|
2022
Q4 | $395K | Sell |
4,601
-210
| -4% | -$16.6K | 0.05% | 139 |
|
|
2022
Q3 | $297K | Buy |
4,811
+49
| +1% | +$3.09K | 0.04% | 162 |
|
|
2022
Q2 | $294K | Buy |
4,762
+165
| +4% | +$10.2K | 0.04% | 161 |
|
|
2022
Q1 | $273K | Buy |
4,597
+102
| +2% | +$6.52K | 0.03% | 173 |
|
|
2021
Q4 | $326K | Sell |
4,495
-1
| -0% | -$69 | 0.04% | 156 |
|
|
2021
Q3 | $314K | Buy |
4,496
+1
| +0% | +$70 | 0.04% | 153 |
|
|
2021
Q2 | $310K | Hold |
4,495
| – | – | 0.04% | 147 |
|
|
2021
Q1 | $291K | Buy |
4,495
+10
| +0.2% | +$645 | 0.04% | 143 |
|
|
2020
Q4 | $261K | Hold |
4,485
| – | – | 0.04% | 146 |
|
|
2020
Q3 | $283K | Sell |
4,485
-39
| -0.9% | -$2.71K | 0.05% | 127 |
|
|
2020
Q2 | $348K | Sell |
4,524
-591
| -12% | -$45.3K | 0.06% | 105 |
|
|
2020
Q1 | $382K | Sell |
5,115
-203
| -4% | -$14K | 0.08% | 113 |
|
|
2019
Q4 | $346K | Hold |
5,318
| – | – | 0.06% | 149 |
|
|
2019
Q3 | $337K | Sell |
5,318
-26
| -0.5% | -$1.7K | 0.06% | 155 |
|
|
2019
Q2 | $361K | Sell |
5,344
-135
| -2% | -$8.88K | 0.06% | 146 |
|
|
2019
Q1 | $356K | Sell |
5,479
-789
| -13% | -$52.4K | 0.06% | 145 |
|
|
2018
Q4 | $392K | Sell |
6,268
-6
| -0.1% | -$419 | 0.08% | 124 |
|
|
2018
Q3 | $484K | Hold |
6,274
| – | – | 0.08% | 105 |
|
|
2018
Q2 | $444K | Sell |
6,274
-647
| -9% | -$45.7K | 0.08% | 107 |
|
|
2018
Q1 | $522K | Sell |
6,921
-6,568
| -49% | -$522K | 0.09% | 103 |
|
|
2017
Q4 | $966K | Sell |
13,489
-3,615
| -21% | -$275K | 0.18% | 88 |
|
|
2017
Q3 | $1.39M | Buy |
17,104
+6,588
| +63% | +$504K | 0.26% | 80 |
|
|
2017
Q2 | $744K | Sell |
10,516
-225
| -2% | -$15K | 0.15% | 86 |
|
|
2017
Q1 | $730K | Sell |
10,741
-2,772
| -21% | -$195K | 0.15% | 85 |
|
|
2016
Q4 | $968K | Sell |
13,513
-1,025
| -7% | -$76.2K | 0.21% | 83 |
|
|
2016
Q3 | $1.15M | Sell |
14,538
-152
| -1% | -$12.3K | 0.25% | 77 |
|
|
2016
Q2 | $1.23M | Sell |
14,690
-59,242
| -80% | -$5.26M | 0.27% | 78 |
|
|
2016
Q1 | $6.79M | Sell |
73,932
-3,358
| -4% | -$303K | 1.53% | 12 |
|
|
2015
Q4 | $7.82M | Sell |
77,290
-1,946
| -2% | -$202K | 1.8% | 7 |
|
|
2015
Q3 | $7.78M | Sell |
79,236
-1,813
| -2% | -$201K | 1.93% | 7 |
|
|
2015
Q2 | $9.49M | Sell |
81,049
-3,055
| -4% | -$334K | 2.07% | 6 |
|
|
2015
Q1 | $8.25M | Sell |
84,104
-9,560
| -10% | -$971K | 1.85% | 7 |
|
|
2014
Q4 | $8.83M | Sell |
93,664
-29,065
| -24% | -$3.01M | 2.12% | 5 |
|
|
2014
Q3 | $13.1M | Sell |
122,729
-319
| -0.3% | -$31.2K | 3.05% | 3 |
|
|
2014
Q2 | $10.2M | Buy |
123,048
+2,065
| +2% | +$161K | 2.29% | 7 |
|
|
2014
Q1 | $8.57M | Sell |
120,983
-41,344
| -25% | -$3.24M | 2.1% | 10 |
|
|
2013
Q4 | $12.2M | Buy |
162,327
+59,124
| +57% | +$4.12M | 3.07% | 1 |
|
|
2013
Q3 | $6.56M | Sell |
103,203
-78,310
| -43% | -$4.68M | 2.4% | 4 |
|
|
2013
Q2 | $9.31M | Buy |
+181,513
| New | +$9.46M | 2.59% | 5 |
|
Other funds holding GILD
VCM
VPM
Howe & Rusling's GILD Position: Q1 2026 in Review
Howe & Rusling reduced its Gilead Sciences (GILD) stake by 0.83% in Q1 2026, selling an estimated $5.46K and leaving 4,637 shares worth $646K. The position accounts for 0.04% of the portfolio, ranked #159.
Howe & Rusling first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Howe & Rusling held 4,637 shares of Gilead Sciences worth $646K as of Q1 2026.
- Howe & Rusling sold 39 Gilead Sciences shares in Q1 2026, an estimated $5.46K.
- Gilead Sciences made up 0.04% of Howe & Rusling's portfolio in Q1 2026, its #159 holding.
- Howe & Rusling first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Howe & Rusling's Gilead Sciences position peaked at $13.1M in Q3 2014.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.